RELIV INTERNATIONAL INC (RELV) financial statements (2023 and earlier)

Company profile

Business Address 136 CHESTERFIELD INDUSTRIAL BLVD
CHESTERFIELD, MO 63006-0405
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,6311,9903,6033,9033,5375,2736,657
Cash and cash equivalents1,6311,9903,2733,6073,2624,9896,657
Short-term investments  330296275284 
Receivables1,22957519521062735298
Inventory, net of allowances, customer advances and progress billings2,7022,9554,5554,4885,1735,1775,215
Inventory2,7022,9554,5554,4885,1735,1775,215
Disposal group, including discontinued operation 2,125     
Deferred tax assets   6661309
Other undisclosed current assets30444143331397669878
Total current assets:5,8668,0868,3968,9329,80011,53313,156
Noncurrent Assets
Operating lease, right-of-use asset354
Property, plant and equipment4,4414,6995,6775,8546,4196,9266,735
Long-term investments and receivables2,4191,2821,4051,5211,6301,7331,830
Due from related parties2,4191,2821,4051,5211,6301,7331,830
Intangible assets, net (including goodwill)1,7221,9482,1742,4002,6562,9263,196
Intangible assets, net (excluding goodwill)1,7221,9482,1742,4002,6562,9263,196
Other noncurrent assets 339337305285296278
Deferred tax assets, net  487623686 
Other undisclosed noncurrent assets505 3,0872,9662,8482,7482,404
Total noncurrent assets:9,4418,26812,68013,53414,46115,31514,443
TOTAL ASSETS:15,30716,35421,07622,46624,26126,84827,599
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3,1313,8803,2004,2343,9385,1875,869
Accounts payable1,5652,1061,6672,3531,8602,0262,969
Accrued liabilities8911,0311,1161,4021,5681,754 
Employee-related liabilities2132102622452771,115 
Taxes payable261231155234233292511
Other undisclosed accounts payable and accrued liabilities201302    2,389
Debt737 2,545389782697581
Other undisclosed current liabilities12135513   200
Total current liabilities:3,9893,9156,2584,6234,7195,8846,649
Noncurrent Liabilities
Long-term debt and lease obligation104  2,5183,1603,0472,632
Long-term debt, excluding current maturities   2,5183,1603,0472,632
Operating lease, liability104
Liabilities, other than long-term debt1134464534105004191,037
Deferred tax liabilities, net   94 127
Other liabilities113446453410406419910
Other undisclosed noncurrent liabilities     5001,150
Total noncurrent liabilities:2164464532,9283,6593,9664,819
Total liabilities:4,2054,3616,7117,5528,3799,85111,468
Stockholders' equity
Stockholders' equity attributable to parent11,10211,99314,36514,91415,88216,99716,130
Common stock2222151515
Treasury stock, value(5,851)(5,339)(5,339)(5,339)(5,339)(5,339)(5,339)
Additional paid in capital30,64430,62330,59930,56530,50030,32230,101
Accumulated other comprehensive loss(937)(982)(858)(1,030)(634)(566)(487)
Accumulated deficit(12,755)(12,311)(10,040)(9,284)(8,659)(7,435)(8,159)
Total stockholders' equity:11,10211,99314,36514,91415,88216,99716,130
TOTAL LIABILITIES AND EQUITY:15,30716,35421,07622,46624,26126,84827,599

Income statement (P&L) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues35,05536,11641,78945,51351,76957,34568,207
Revenue, net41,78945,51351,76957,34568,207
Cost of revenue
(Cost of Goods and Services Sold)
(9,557)(9,710)(9,401)(10,024)(11,086)(11,658)(14,023)
Gross profit:25,49826,40632,38735,48940,68345,68754,184
Operating expenses(14,799)(16,521)(17,885)(36,301)(41,957)(46,970)(54,121)
Other undisclosed operating income (loss)(11,259)(11,750)(14,686)  1,3791,439
Operating income (loss):(559)(1,864)(183)(812)(1,274)961,502
Nonoperating income (expense)184187161450(184)(156)12
Investment income, nonoperating17893102107117132149
Foreign currency transaction gain (loss), before tax(11)3321148(109)(137) 
Other nonoperating income (expense)186239196(191)(151)(138)
Interest and debt expense(47)(96)(109)(107)(114)(100)(82)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes446(33)(21)(148)109137 
Income (loss) from continuing operations before income taxes:24(1,805)(152)(616)(1,463)(23)1,432
Income tax expense (benefit)(468)(98)(545)(9)238748(655)
Net income (loss) available to common stockholders, diluted:(444)(1,903)(697)(625)(1,225)725777

Comprehensive Income ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(444)(1,903)(697)(625)(1,225)725777
Other comprehensive income     646784
Comprehensive income (loss):(444)(1,903)(697)(625)(1,225)1,3711,560
Other undisclosed comprehensive income (loss), net of tax, attributable to parent45(124)114(396)(68)(725)(777)
Comprehensive income (loss), net of tax, attributable to parent:(400)(2,028)(583)(1,021)(1,293)646784

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: